Compound 47 showed cytotoxic activity selectively against STAT3-dependent MDA-MB-231 breast cancer cell line (IC50 of 5.35 μM), whereas it was practically inactive towards STAT3 null A4 cancer cell line (IC50 > 100 μM against), suggesting a STAT3-specific inhibition. This evidence concerns the gene STAT3 and breast cancer.